Crystal Structure of a TAF1-TAF7 Complex in Human Transcription Factor IID Reveals a Promoter Binding Module
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice
Loyola University Chicago Loyola eCommons Biology: Faculty Publications and Other Works Faculty Publications 2013 Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice Mihaela Palicev Gunter P. Wagner James P. Noonan Benedikt Hallgrimsson James M. Cheverud Loyola University Chicago, [email protected] Follow this and additional works at: https://ecommons.luc.edu/biology_facpubs Part of the Biology Commons Recommended Citation Palicev, M, GP Wagner, JP Noonan, B Hallgrimsson, and JM Cheverud. "Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice." Genome Biology and Evolution 5(10), 2013. This Article is brought to you for free and open access by the Faculty Publications at Loyola eCommons. It has been accepted for inclusion in Biology: Faculty Publications and Other Works by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. © Palicev et al., 2013. GBE Genomic Correlates of Relationship QTL Involved in Fore- versus Hind Limb Divergence in Mice Mihaela Pavlicev1,2,*, Gu¨ nter P. Wagner3, James P. Noonan4, Benedikt Hallgrı´msson5,and James M. Cheverud6 1Konrad Lorenz Institute for Evolution and Cognition Research, Altenberg, Austria 2Department of Pediatrics, Cincinnati Children‘s Hospital Medical Center, Cincinnati, Ohio 3Yale Systems Biology Institute and Department of Ecology and Evolutionary Biology, Yale University 4Department of Genetics, Yale University School of Medicine 5Department of Cell Biology and Anatomy, The McCaig Institute for Bone and Joint Health and the Alberta Children’s Hospital Research Institute for Child and Maternal Health, University of Calgary, Calgary, Canada 6Department of Anatomy and Neurobiology, Washington University *Corresponding author: E-mail: [email protected]. -
Gene-Set Libraries from Chip-X Experiments to Decode the Transcription Regulome Yan Kou, Edward Chen, Neil Clark, Qiaonan Duan, Christopher Tan, Avi Ma‘Ayan
ChEA2: Gene-Set Libraries from ChIP-X Experiments to Decode the Transcription Regulome Yan Kou, Edward Chen, Neil Clark, Qiaonan Duan, Christopher Tan, Avi Ma‘ayan To cite this version: Yan Kou, Edward Chen, Neil Clark, Qiaonan Duan, Christopher Tan, et al.. ChEA2: Gene-Set Libraries from ChIP-X Experiments to Decode the Transcription Regulome. 1st Cross-Domain Con- ference and Workshop on Availability, Reliability, and Security in Information Systems (CD-ARES), Sep 2013, Regensburg, Germany. pp.416-430. hal-01506771 HAL Id: hal-01506771 https://hal.inria.fr/hal-01506771 Submitted on 12 Apr 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License ChEA2: Gene-Set Libraries from ChIP-X Experiments to Decode the Transcription Regulome Yan Kou1, Edward Y. Chen1, Neil R. Clark1, Qiaonan Duan1, Christopher M. Tan1, Avi Ma‘ayan1,* 1Department of Pharmacology and Systems Therapeutics, Systems Biology Center New York (SBCNY), Icahn School of Medicine at Mount Sinai, New York, NY 10029 * To whom correspondence should be addressed: avi.maayan[at]mssm.edu Abstract. ChIP-seq experiments provide a plethora of data regarding transcription regulation in mammalian cells. -
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated. -
High-Resolution Structure of TBP with TAF1 Reveals Anchoring Patterns in Transcriptional Regulation
ARTICLES High-resolution structure of TBP with TAF1 reveals anchoring patterns in transcriptional regulation Madhanagopal Anandapadamanaban1, Cecilia Andresen1,6, Sara Helander1,6, Yoshifumi Ohyama2, Marina I Siponen3,5, Patrik Lundström1, Tetsuro Kokubo2, Mitsuhiko Ikura4, Martin Moche3 & Maria Sunnerhagen1 The general transcription factor TFIID provides a regulatory platform for transcription initiation. Here we present the crystal structure (1.97 Å) and NMR analysis of yeast TAF1 N-terminal domains TAND1 and TAND2 bound to yeast TBP, together with mutational data. We find that yeast TAF1-TAND1, which in itself acts as a transcriptional activator, binds TBP’s concave DNA- binding surface by presenting similar anchor residues to TBP as does Mot1 but from a distinct structural scaffold. Furthermore, we show how TAF1-TAND2 uses an aromatic and acidic anchoring pattern to bind a conserved TBP surface groove traversing the basic helix region, and we find highly similar TBP-binding motifs also presented by the structurally distinct TFIIA, Mot1 and Brf1 proteins. Our identification of these anchoring patterns, which can be easily disrupted or enhanced, provides insight into the competitive multiprotein TBP interplay critical to transcriptional regulation. Initiation of eukaryotic gene transcription at a core promoter requires DNA binding and recruitment of the transcriptional machinery13. the assembly of a preinitiation complex (PIC). These complexes are However, although the DNA anchoring in this model is well estab- biologically dynamic assemblies, and their composition can be altered lished12, recruiting activation-domain complexes have been charac- during development and thereby drive cell-specific programs of tran- terized only at low resolution14–17. Furthermore, although TBP has scription1,2. -
Revealing Transcription Factor and Histone Modification Co-Localization and Dynamics Across Cell Lines by Integrating Chip-Seq A
Zhang et al. BMC Genomics 2018, 19(Suppl 10):914 https://doi.org/10.1186/s12864-018-5278-5 RESEARCH Open Access Revealing transcription factor and histone modification co-localization and dynamics across cell lines by integrating ChIP-seq and RNA-seq data Lirong Zhang1*, Gaogao Xue1, Junjie Liu1, Qianzhong Li1* and Yong Wang2,3,4* From 29th International Conference on Genome Informatics Yunnan, China. 3-5 December 2018 Abstract Background: Interactions among transcription factors (TFs) and histone modifications (HMs) play an important role in the precise regulation of gene expression. The context specificity of those interactions and further its dynamics in normal and disease remains largely unknown. Recent development in genomics technology enables transcription profiling by RNA-seq and protein’s binding profiling by ChIP-seq. Integrative analysis of the two types of data allows us to investigate TFs and HMs interactions both from the genome co-localization and downstream target gene expression. Results: We propose a integrative pipeline to explore the co-localization of 55 TFs and 11 HMs and its dynamics in human GM12878 and K562 by matched ChIP-seq and RNA-seq data from ENCODE. We classify TFs and HMs into three types based on their binding enrichment around transcription start site (TSS). Then a set of statistical indexes are proposed to characterize the TF-TF and TF-HM co-localizations. We found that Rad21, SMC3, and CTCF co-localized across five cell lines. High resolution Hi-C data in GM12878 shows that they associate most of the Hi-C peak loci with a specific CTCF-motif “anchor” and supports that CTCF, SMC3, and RAD2 co-localization serves important role in 3D chromatin structure. -
Therapeutic Potential of TAF1 Bromodomains for Cancer Treatment
bioRxiv preprint doi: https://doi.org/10.1101/394254; this version posted August 17, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Therapeutic potential of TAF1 bromodomains for cancer treatment Veronica Garcia-Carpizo1, Sergio Ruiz-Llorente1, Jacinto Sarmentero1 and Maria J. Barrero1* 1CNIO-Lilly Epigenetics Laboratory Spanish National Cancer Research Center (CNIO), Melchor Fernandez Almagro 3, E-28029 Madrid, Spain *To whom correspondence should be addressed: [email protected] (34) 917 328 000 Keywords: epigenetics, bromodomains, proliferation, cancer Running tittle: TAF1 bromodomains in proliferation 1 bioRxiv preprint doi: https://doi.org/10.1101/394254; this version posted August 17, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. ABSTRACT The discovery of the antiproliferative effects of BRD4 bromodomain inhibitors prompted us to investigate additional bromodomains that might be involved in supporting cellular proliferation. TAF1 is a general transcription factor with two bromodomains that is likely to play important roles in cell viability by supporting transcription. Our work shows that knock down of TAF1 caused antiproliferative effects in several cancer cell lines. Using CRISPR-Cas9 editing techniques we demonstrate that the bromodomains of TAF1 are essential to maintain proliferation of K562 and H322 cells. BAY-299, the best TAF1 bromodomain inhibitor developed so far, also showed antiproliferative effects. BAY-299 caused discrete transcriptional changes that were likely on target but did not correlate with strong effects in cell cycle distribution suggesting that these effects might be, at least in part, mediated by another target. -
Dual Functions of TAF7L in Adipocyte Differentiation
RESEARCH ARTICLE elife.elifesciences.org Dual functions of TAF7L in adipocyte differentiation Haiying Zhou1,2, Tommy Kaplan3,4, Yan Li5, Ivan Grubisic2,6, Zhengjian Zhang5, P Jeremy Wang7, Michael B Eisen1,3, Robert Tjian1,2* 1Department of Molecular and Cell Biology, Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, United States; 2Li Ka Shing Center For Biomedical and Health Sciences, CIRM Center of Excellence, University of California, Berkeley, Berkeley, United States; 3Department of Molecular and Cell Biology, California Institute of Quantitative Biosciences, University of California, Berkeley, Berkeley, United States; 4School of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel; 5Janelia Farm Research Campus, Howard Hughes Medical Institute, Ashburn, United States; 6UC Berkeley-UCSF Graduate Program in Bioengineering, Department of Molecular and Cell Biology, California Institute of Quantitative Biosciences, University of California, Berkeley, Berkeley, United States; 7Department of Animal Biology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, United States Abstract The diverse transcriptional mechanisms governing cellular differentiation and development of mammalian tissue remains poorly understood. Here we report that TAF7L, a paralogue of TFIID subunit TAF7, is enriched in adipocytes and white fat tissue (WAT) in mouse. Depletion of TAF7L reduced adipocyte-specific gene expression, compromised adipocyte differentiation, and WAT development as well. Ectopic expression of TAF7L in myoblasts reprograms these muscle precursors into adipocytes upon induction. Genome-wide mRNA-seq expression profiling and ChIP-seq binding studies confirmed that TAF7L is required for activating adipocyte-specific genes via a dual mechanism wherein it interacts with PPARγ at enhancers and TBP/Pol II at core promoters. -
TAF1 Antibody
For research use only BioVision 09/14 TAF1 Antibody ALTERNATE NAMES: TAF (II) 250, TBP-associated factor 250 kDa, p250, BA2R, CCG1, CCGS, TAF2A CATALOG #: 6845-50 AMOUNT: 50 µl HOST/ISOTYPE: Rabbit Western blot was performed on nuclear IMMUNOGEN: Polyclonal antibody raised in rabbit against human TAF1 extracts from HeLa cells (20 µg) with (TATA box binding protein (TBP)-associated factor; the antibody diluted 1:1,000 in TBS- Transcription initiation factor TFIID subunit 1), using the Tween containing 5% skimmed milk recombinant double bromodomain module of the protein. (Figure 2). The molecular weight marker (in kDa) is shown on the left; FORM: Liquid the location of the protein of interest is indicated on the right. FORMULATION: In PBS with 0.05% (W/V) sodium azide. PURIFICATION: Whole antiserum from rabbit SPECIES REACTIVITY: Human. STORAGE CONDITIONS: Store at -20°C; for long storage, store at -80°C. Avoid multiple freeze-thaw cycles. DESCRIPTION: TAF1 is the largest component and core scaffold of the TFIID basal transcription factor complex which also includes TBP. The protein is able to auto phosphorylate or trans phosphorylate other transcription factors such as TP53 on ‘Thr- 55’, leading to MDM2-mediated degradation of TP53, and GTF2A1 and GTF2F1 on Ser residues. TAF1 possesses DNA- RELATED PRODUCTS: binding activity and is essential for progression of the G1 phase TAF1 bromodomain 1 (1371-1496 aa) (GST-tagged), Human recombinant (Cat # 7660- of the cell cycle. 20, -100) APPLICATION: Western Blot: 1:1000. Note: This information is only intended as a guide. The optimal dilutions must be FOR RESEARCH USE ONLY! Not to be used on humans. -
TAF1 Gene TATA-Box Binding Protein Associated Factor 1
TAF1 gene TATA-box binding protein associated factor 1 Normal Function The TAF1 gene provides instructions for making part of a protein called transcription factor IID (TFIID). This protein is active in cells and tissues throughout the body, where it attaches (binds) to DNA. Transcription factor IID plays an essential role in regulating the activity of most genes. The TAF1 gene is part of a complex region of DNA known as the TAF1/DYT3 multiple transcript system. This region consists of short stretches of DNA from the TAF1 gene plus some extra segments of genetic material near the gene. These stretches of DNA can be combined in different ways to create various sets of instructions for making proteins. Researchers believe that some of these variations are critical for the normal function of nerve cells (neurons) in the brain. Health Conditions Related to Genetic Changes X-linked dystonia-parkinsonism Several changes in the TAF1/DYT3 multiple transcript system have been identified in people with X-linked dystonia-parkinsonism. Some alter single DNA building blocks ( nucleotides) in the gene; these changes are described as disease-specific single- nucleotide changes (DSCs). Another genetic change deletes a small number of nucleotides from the gene. Researchers are uncertain how these changes are related to the movement abnormalities characteristic of the disease. X-linked dystonia-parkinsonism may also be related to an extra segment of DNA in the TAF1/DYT3 multiple transcript system. The extra segment results from the insertion of a retrotransposon, which is a small piece of DNA that can move around to different positions in a cell's genetic material. -
Non-Canonical TAF Complexes Regulate Active Promoters in Human Embryonic Stem Cells
University of Massachusetts Medical School eScholarship@UMMS Program in Gene Function and Expression Publications and Presentations Molecular, Cell and Cancer Biology 2012-11-13 Non-canonical TAF complexes regulate active promoters in human embryonic stem cells Glenn A. Maston University of Massachusetts Medical School Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/pgfe_pp Part of the Genetics and Genomics Commons Repository Citation Maston GA, Zhu LJ, Chamberlain L, Lin L, Fang M, Green MR. (2012). Non-canonical TAF complexes regulate active promoters in human embryonic stem cells. Program in Gene Function and Expression Publications and Presentations. https://doi.org/10.7554/eLife.00068. Retrieved from https://escholarship.umassmed.edu/pgfe_pp/211 This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Program in Gene Function and Expression Publications and Presentations by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. RESEARCH ARTICLE elife.elifesciences.org Non-canonical TAF complexes regulate active promoters in human embryonic stem cells Glenn A Maston1,2, Lihua Julie Zhu1,3, Lynn Chamberlain1,2, Ling Lin1,2, Minggang Fang1,2, Michael R Green1,2* 1Programs in Gene Function and Expression and Molecular Medicine, University of Massachusetts Medical School, Worcester, United States; 2Howard Hughes Medical Institute, Chevy Chase, United States; 3Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, United States Abstract The general transcription factor TFIID comprises the TATA-box-binding protein (TBP) and approximately 14 TBP-associated factors (TAFs). -
Structures of Three Distinct Activator–TFIID Complexes
Downloaded from genesdev.cshlp.org on October 1, 2021 - Published by Cold Spring Harbor Laboratory Press Structures of three distinct activator–TFIID complexes Wei-Li Liu,1 Robert A. Coleman,1 Elizabeth Ma,1 Patricia Grob,2 Joyce L. Yang,1 Yixi Zhang,1 Gina Dailey,1 Eva Nogales,2 and Robert Tjian1,3 1Howard Hughes Medical Institute, Molecular and Cell Biology Department, University of California at Berkeley, Berkeley, California 94720, USA; 2Howard Hughes Medical Institute, Molecular and Cell Biology Department, University of California at Berkeley and Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA Sequence-specific DNA-binding activators, key regulators of gene expression, stimulate transcription in part by targeting the core promoter recognition TFIID complex and aiding in its recruitment to promoter DNA. Although it has been established that activators can interact with multiple components of TFIID, it is unknown whether common or distinct surfaces within TFIID are targeted by activators and what changes if any in the structure of TFIID may occur upon binding activators. As a first step toward structurally dissecting activator/TFIID interactions, we determined the three-dimensional structures of TFIID bound to three distinct activators (i.e., the tumor suppressor p53 protein, glutamine-rich Sp1 and the oncoprotein c-Jun) and compared their structures as determined by electron microscopy and single-particle reconstruction. By a combination of EM and biochemical mapping analysis, our results uncover distinct contact regions within TFIID bound by each activator. Unlike the coactivator CRSP/Mediator complex that undergoes drastic and global structural changes upon activator binding, instead, a rather confined set of local conserved structural changes were observed when each activator binds holo- TFIID. -
Decreased N-TAF1 Expression in X-Linked Dystonia-Parkinsonism Patient-Specific Neural Stem Cells Naoto Ito1,2,*, William T
© 2016. Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2016) 9, 451-462 doi:10.1242/dmm.022590 RESOURCE ARTICLE Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cells Naoto Ito1,2,*, William T. Hendriks1,2,*, Jyotsna Dhakal1,2, Christine A. Vaine1,2, Christina Liu1,2, David Shin1,2, Kyle Shin1,2, Noriko Wakabayashi-Ito1,2, Marisela Dy1, Trisha Multhaupt-Buell1, Nutan Sharma1, Xandra O. Breakefield1,2,3,‡ and D. Cristopher Bragg1,2,‡ ABSTRACT et al., 2013a). Most cases in which dystonia is the primary clinical manifestation seem to have a genetic predisposition, with over 25 X-linked dystonia-parkinsonism (XDP) is a hereditary neurodegenerative gene loci linked to different forms of the disease (Lohmann and disorder involving a progressive loss of striatal medium spiny neurons. Klein, 2013). Among the many subtypes of dystonia are numerous The mechanisms underlying neurodegeneration are not known, in examples that combine clinical features of Parkinson’s disease part because there have been few cellular models available for (PD), such as (1) DOPA-responsive dystonia, caused by variations studying the disease. The XDP haplotype consists of multiple in genes encoding dopamine biosynthetic enzymes (GCH1, TH, sequence variations in a region of the X chromosome containing SR; Lee and Jeon, 2014); (2) rapid-onset dystonia-parkinsonism TAF1, a large gene with at least 38 exons, and a multiple transcript (RDP), caused by variations in a subunit of the sodium/potassium system (MTS) composed of five unconventional exons. A previous ATPase (ATP1A3; Geyer and Bressman, 2011); (3) DYT16 study identified an XDP-specific insertion of a SINE-VNTR-Alu dystonia, associated with variations in the PKR regulatory (SVA)-type retrotransposon in intron 32 of TAF1, as well as a neural- protein, PACT (PRKRA; Zech et al., 2014; Camargos et al., specific TAF1 isoform, N-TAF1, which showed decreased expression 2012); and (4) other degenerative disorders such as Wilson’s in post-mortem XDP brain compared with control tissue.